MethodSense Helps Medical Device Companies Meet FDA’s Tougher Draft Guidance for Pulse Oximeters

New FDA Draft Guidance Raises the Bar on Pulse Oximeter Accuracy – MethodSense Leads the Way in Compliance, Clinical Validation, and Regulatory Strategy Morrisville, NC – February 27, 2025 – MethodSense, a leading regulatory and quality consulting firm, is leveraging its deep expertise to guide pulse oximeter manufacturers through the new FDA draft guidance aimed…